Synexa is an industry leader in contract bioanalytics and biomarker research services specializing in biopharmaceutical, supporting Biopharma partners across the globe to achieve their clinical milestones with bespoke analytical solutions to meet specific challenges.
Our global purpose-built laboratories have been designed and fitted to meet the fast changing and ever evolving complexity of drug development pipelines.
Guided by a combined scientific experience of over 800 years, our team of world-class scientists pride themselves on going the extra mile to deliver high levels of customer service and quality science that meets your expectations.
We specialize in providing quality scientific expertise in key disease areas, encompassing a wide range of technology platforms and bespoke assay solutions to meet each outcome.
Services include protein, cell and gene therapy bioanalytics, biomarker discovery, analysis and validation, PK/PD, de novo assay method development and validation, and ProtoTrials®, a proprietary human in vivo translational research platform focused on providing valuable early clinical insights.